CLAIM CARD
Within the corpus, this evidence is specific to a high-comorbidity subgroup. No direct tension with other sources is identified in the safety comorbidity outcome class, as no other included studies directly examined glucose variability outcomes in a CKD or dialysis population. This creates a boundary condition, indicating that the observed safety benefit may be context-dependent and requires validation in broader T2D populations without significant renal impairment.
Evidence grade: exploratory
Contradiction status: none
Publication: becb4785-6244-41cd-ba08-c47e58dca346
Provenance: Derivation Web chain
Citation Support
source_1Sidki 2026source_2Gravesteijn 2023source_3Lu 2021source_4Lee 2020source_5Franceschi 2026